These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30838381)

  • 1. Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis.
    Dao A; Abidian M; Lestrange A; Mattar M; Rangnekar A; Charabaty A
    Inflamm Bowel Dis; 2019 Jun; 25(7):e90-e91. PubMed ID: 30838381
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.
    de Chambrun GP; Nachury M; Funakoshi N; Gerard R; Bismuth M; Valats JC; Panaro F; Navarro F; Desreumaux P; Pariente B; Blanc P
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1247-1252. PubMed ID: 30052539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease.
    Cox KL; Cox KM
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):580-3. PubMed ID: 9822326
    [No Abstract]   [Full Text] [Related]  

  • 4. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine-induced bronchiolitis obliterans organizing pneumonia (BOOP) in a patient with ulcerative colitis and primary sclerosing cholangitis.
    Kevans D; Greene J; Galvin L; Morgan R; Murray FE
    Inflamm Bowel Dis; 2011 Oct; 17(10):E137-8. PubMed ID: 21761513
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of oral vancomycin in inducing remission for biologic-experienced ulcerative colitis with concomitant primary sclerosing cholangitis and liver transplantation.
    Rahman AU; Inayat F; Ali S; Zahid E; Charles R
    Clin J Gastroenterol; 2021 Feb; 14(1):159-164. PubMed ID: 33130984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis.
    Ahmed T; Kayal M; Hashem D; Ungaro RC
    Dig Dis Sci; 2023 Apr; 68(4):1118-1120. PubMed ID: 36881200
    [No Abstract]   [Full Text] [Related]  

  • 8. How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Shah A; Pakneeshan S; Jones MP; Koloski N; Callaghan G; Morrison M; Holtmann G
    Indian J Gastroenterol; 2022 Oct; 41(5):519-524. PubMed ID: 36217097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis.
    Halma JC; Cristoferi L; Carbone M
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2699-2700. PubMed ID: 36442726
    [No Abstract]   [Full Text] [Related]  

  • 10. Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin.
    Sandborn WJ; Wiesner RH; Tremaine WJ; Larusso NF
    Gut; 1993 Feb; 34(2):242-6. PubMed ID: 8432481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Ulcerative Colitis Using Vedolizumab After Liver Transplantation for Primary Sclerosing Cholangitis.
    Meszaros M; Pageaux GP; Altwegg R
    J Crohns Colitis; 2016 Feb; 10(2):236. PubMed ID: 26449788
    [No Abstract]   [Full Text] [Related]  

  • 12. Ulcerative colitis and primary sclerosing cholangitis as part of autoimmune polyglandular syndrome type III.
    Farkas K; Nagy F; Kovács L; Csajbók E; Kovács G; Wittmann T; Molnár T
    Inflamm Bowel Dis; 2010 Jan; 16(1):10-1. PubMed ID: 19322903
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinct Disease Phenotype of Ulcerative Colitis in Patients With Coincident Primary Sclerosing Cholangitis: Evidence From a Large Retrospective Study With Matched Cohorts.
    Cordes F; Laumeyer T; Gerß J; Brückner M; Lenze F; Nowacki T; Rijcken E; Tepasse P; Schmidt H; Kucharzik T; Bettenworth D
    Dis Colon Rectum; 2019 Dec; 62(12):1494-1504. PubMed ID: 31725582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
    Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
    Chaparro M; Trapero-Marugán M; Guijarro M; López C; Moreno-Otero R; Gisbert JP
    J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Gurbuz AK; Giardiello FM; Bayless TM
    Dis Colon Rectum; 1995 Jan; 38(1):37-41. PubMed ID: 7813342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
    Ricciuto A; Liu K; El-Matary W; Amin M; Amir AZ; Aumar M; Auth M; Di Guglielmo MD; Druve Tavares Fagundes E; Rodrigues Ferreira A; Furuya KN; Gupta N; Guthery S; Horslen SP; Jensen K; Kamath BM; Kerkar N; Koot BGP; Laborda TJ; Lee CK; Loomes KM; Mack C; Martinez M; Montano-Loza A; Ovchinsky N; Papadopoulou A; Perito ER; Sathya P; Schwarz KB; Shah U; Shteyer E; Soufi N; Stevens JP; Taylor A; Tessier ME; Valentino P; Woynarowski M; Deneau M;
    Aliment Pharmacol Ther; 2024 May; 59(10):1236-1247. PubMed ID: 38462727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
    Tan LZ; Reilly CR; Steward-Harrison LC; Balouch F; Muir R; Lewindon PJ
    Gut; 2019 Aug; 68(8):1533-1535. PubMed ID: 30131321
    [No Abstract]   [Full Text] [Related]  

  • 19. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
    Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
    Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis.
    Damman JL; Rodriguez EA; Ali AH; Buness CW; Cox KL; Carey EJ; Lindor KD
    Aliment Pharmacol Ther; 2018 Apr; 47(7):886-895. PubMed ID: 29411404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.